MODIFIED TUMOR-INFILTRATING LYMPHOCYTE AND USE THEREOF

COMBINATION OF A CAR T CELL THERAPY AND AN IMMUNOMODULATORY COMPOUND FOR TREATMENT OF LYMPHOMA

Virus-like Particles with Programmable Tropism and Methods of Use Thereof for Delivery to Cells

NOVEL CHIMERIC ANTIGEN RECEPTORS AND LIBRARIES

CHIMERIC ANTIGEN RECEPTOR THAT RECOGNIZES CCR8 AS ANTIGEN

FUSION MOLECULES TARGETING VEGF AND ANGIOPOIETIN AND USES THEREOF

SIGNAL SEQUENCE THAT INDUCES PROTEIN SECRETION IN INTESTINAL MICROBIOME

CHIMERIC ANTIGEN RECEPTOR WITH MODIFIED HINGE AND TRANSMEMBRANE DOMAIN AND USES THEREOF

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

BLOCKADE OF CD7 EXPRESSION AND CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY OF T-CELL MALIGNANCIES

CLDN18.2 ANTIGEN-BINDING PROTEIN AND USE THEREOF

CHIMERIC APOPTOTIC SIGNAL TARGETING LYMPHOCYTES (TIM-4 CASTL) AND METHODS OF MAKING AND USING SAME

CHIMERIC ANTIGEN RECEPTOR TARGETING ONCOLYTIC VIRUS-DERIVED PROTEIN, IMMUNOCYTE EXPRESSING SAME, AND USES OF BOTH

SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION

CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

METHODS FOR DOSING AND TREATMENT WITH A COMBINATION OF A CHECKPOINT INHIBITOR THERAPY AND A CAR T CELL THERAPY

CHIMERIC ENGULFMENT RECEPTOR MOLECULES AND METHODS OF USE

SYNTHETIC SIGNAL PEPTIDES FOR DIRECTING SECRETION OF HETEROLOGOUS PROTEINS IN YEAST

GENERATION OF CD3 EXPRESSING IMMUNE CELLS FOR USE IN CONJUNCTION WITH CD3 BINDING BISPECIFIC TARGETING AGENTS

RNA-GUIDED NUCLEIC ACID MODIFYING ENZYMES AND METHODS OF USE THEREOF

MOLECULES THAT BIND TO CD66e POLYPEPTIDES

CHIMERIC ANTIGEN RECEPTORS TARGETING CANCER

ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

CD33 EXON 2 DEFICIENT DONOR STEM CELLS FOR USE WITH CD33 TARGETING AGENTS

SYNTHETIC PRE-PROTEIN SIGNAL PEPTIDES FOR DIRECTING SECRETION OF HETEROLOGOUS PROTEINS IN BACILLUS BACTERIA

CAR-T DELIVERY OF SYNTHETIC PEPTIDE THERAPEUTICS

Engineered bacteria secreting therapeutic proteins and methods of use thereof

METHODS AND AGENTS FOR MODULATING ADOPTIVE IMMUNOTHERAPY

METHODS TO PROTECT TRANSPLANTED TISSUE FROM REJECTION

COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS

CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENIFYING AGENTS THAT MODULATE MYC

HUMAN APPLICATION OF ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

RECOMBINANT TIM-4 PROTEIN, CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL DELIVERY SYSTEM AND METHODS OF MAKING AND USING SAME

ARTICLES OF MANUFACTURE AND METHODS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY

ONCOLYTIC VIROTHERAPY WITH INDUCED ANTI-TUMOR IMMUNITY

FUSION CONSTRUCTS AS PROTEIN OVER-EXPRESSION VECTORS

GENE CODING FOR CHIMERIC RECEPTOR FOR ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY

GENOME-EDITED INVARIANT NATURAL KILLER T (INKT) CELLS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES

Compositions and Methods for Producing High Secreted Yields of Recombinant Proteins

ENGINEERED IMMUNE CELLS AND USES THEREOF

CHIMERIC PHAGOCYTIC RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

UNIVERSAL CAR-T CELL TARGETING GD2, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING MOLECULES FOR CONTROLLED AND SPECIFIC CAR T CELL ACTIVITY

NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE

HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION

DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY

MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF

REPORTER PROTEIN FUSED ANTIBODIES

TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

T CELLS FOR USE IN THERAPY

ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN

D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

ANTI-CD20 ANTIBODY AND USES THEREOF

ANTI-CD20 ANTIBODY AND USES THEREOF

IMMUNOASSAYS AND ENGINEERED PROTEINS FOR MONITORING ANTIBODY TREATMENTS TO THE IMMUNE CHECKPOINT INHIBITORS PD1 AND PD-L1

CHIMERIC ANTIGEN RECEPTORS TARGETING ABNORMAL GLYCOBIOLOGY

MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF

MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF

PREPARATION METHOD AND APPLICATION OF CTL CELL

CD19 BINDERS, CAR-T CONSTRUCTS COMPRISING THE SAME, AND METHODS OF USING THE SAME

CHIMERIC ANTIGEN RECEPTOR FUSION PROTEIN CO-EXPRESSING IL-7 AND CCR2B, AND APPLICATION THEREOF

FAP BINDING MOLECULES AND USES THEREOF

POLYPEPTIDE

METHODS OF EXOGENOUS DRUG ACTIVATION OF CHEMICAL-INDUCED SIGNALING COMPLEXES EXPRESSED IN ENGINEERED CELLS IN VITRO AND IN VIVO

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

VACCINES AGAINST ZIKA VIRUS

Chimeric Antigen Receptor Specific for Folate Receptor 1

Compositions and Methods for Treating Cancer with Anti-CD22 Immunotherapy

Improved LAMP Constructs Comprising Cancer Antigens

T CELL RECEPTORS THAT BIND TO NY-ESO-1 AND METHODS OF USE THEREOF

ANTIBODY-DERIVED T CELL ACTIVATING TECHNOLOGIES

HLA-DR CAR-T COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

NOVEL CAR

Immunosuppressive antigen-specific chimeric antigen receptor Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders

LAMP constructs

SECRETABLE PAYLOAD REGULATION

ENGINEERED IMMUNE CELL

BI-SPECIFIC CAR T CCELLS FOR B CELL MALIGNANCIES

M971 CHIMERIC ANTIGEN RECEPTORS

M971 CHIMERIC ANTIGEN RECEPTORS

Artificial Transmembrane Proteins for Detecting Intracellular or Intravesicular Biomolecular Interactions

BISPECIFIC CHIMERIC ANTIGEN RECEPTORS BINDING TO CD19 AND CD22

BISPECIFIC CS1-BCMA CAR-T CELL AND APPLICATION THEREOF

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

THERAPEUTIC AGENTS

IL-15-BASED FUSIONS TO IL-7 AND IL-21

SINGLE-CHAIN TNF RECEPTOR 2 AGONIST FUSION PROTEINS

KHL POLYPEPTIDE, AND USE THEREOF IN PREPARATION OF TABP-EIC CELL

Interleukin-37, Chimeric Antigen Receptors, Nucleic Acids, and Vectors Encoding the Same and Uses in Cancer Therapies

CHIMERIC RECEPTOR CONSTRUCTS FOR NK CELLS

Cell

Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)

Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy

GUCY2C BINDING MOLECULES AND USES THEREOF

ANTI-B7H3 CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF

CHIMERIC TIM4 RECEPTORS AND USES THEREOF

NOVEL ANTI-CD24 ANTIBODIES

ROR1-TARGETING ANTIBODY AND USE THEREOF

INDUCIBLE SIGNALLING PROTEIN

TRUNCATED BODY OF IL7Ra AND USE THEREOF IN PREPARATION OF MEDICATION FOR TREATING TUMOR

SYSTEMS AND METHODS TO LINK CD40 SIGNALING TO ANTIGEN BINDING

RECOMBINANT MICROALGAE ABLE TO PRODUCE KTTKS PEPTIDES, POLYPEPTIDES, OR PROTEINS AND THEIR DERIVATIVES AND ASSOCIATED METHOD AND USES THEREOF

Ligand discovery and gene delivery via retroviral surface display

EXPRESSION AND SECRETION SYSTEM

Compositions and Methods for Treating Cancer with DuoCARs

Vesicle Targeting Proteins And Uses Of Same

ANTIGEN RECOGNIZING RECEPTORS TARGETING GD3 GANGLIOSIDE AND USES THEREOF

MOLECULES THAT BIND TO MESOTHELIN POLYPEPTIDES

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19/CD20 IMMUNOTHERAPY

Cell

CELL

RECOMBINANT NEPROSIN POLYPEPTIDES AND METHODS OF EXPRESSION

Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH DUOCARS

NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE

BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T CELLS

ANTIBODY SPECIFIC FOR GPC3 AND USES THEREOF

Anti-GPC3 antibody

CHIMERIC ANTIGEN RECEPTOR

METHODS AND COMPOSITIONS FOR DEPLETING NATURAL KILLER CELLS AND USES THEREOF IN CELLULAR THERAPIES

EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY

ENGINEERED IMMUNE CELL AND USE THEREOF

A CHIMERIC ANTIGEN RECEPTOR CONSTRUCT ENCODING A CHECKPOINT INHIBITORY MOLECULE AND AN IMMUNE STIMULATORY CYTOKINE AND CAR-EXPRESSING CELLS RECOGNIZING CD44v6

CHIMERIC ANTIGEN RECEPTOR COMPRISING NOVEL CO-STIMULATORY DOMAIN AND USE THEREOF

CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

Chimeric antigen receptor for tumor targeting

Methods and compositions for modulating CAR-T activity

FULLY HUMAN ANTIBODY TARGETING CD5, AND FULLY HUMAN CHIMERIC ANTIGEN RECEPTOR (CAR) AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8 AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS

Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer

ANTI-CD20 ANTIBODY AND USES THEREOF

PRION-FC REGION FUSION PROTEIN AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE

ALPHA AMYLASES IN FEED

METHODS FOR DONOR CELL ANALYSIS

FUSION PROTEIN AND USE THEREOF

WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES

Fluorescent fusion based heterologous peptide production

POTENT BINDING AGENTS FOR ACTIVATION OF THE HEDGEHOG SIGNALING PATHWAY

MODIFIED VACCINE DESIGN DEVELOPMENTS

CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTIGEN BINDING DOMAIN SPECIFIC FOR MSLN HAVING A SPECIFICITY FOR TUMOR CELLS

MULTIPLEX GENE EDITED CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY

BACTERIA BASED PROTEIN DELIVERY

DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISING IL-13 AND CHLOROTOXIN FOR CANCER TREATMENT

CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF CANCER

RECOMBINANT VECTOR COMPRISING HYBRID SIGNAL SEQUENCE, AND SECRETORY PREPARATION METHOD OF HUMAN INSULIN-LIKE GROWTH FACTOR-1 USING THE SAME

HUMANIZED ANTIBODY SPECIFIC FOR CD22 AND CHIMERIC ANTIGEN RECEPTOR USING THE SAME

CHIMERIC ANTIGEN RECEPTOR, REGULATORY CELLS AND METHODS OF USE

CLEC2 FUSION PROTEIN AND USES THEREOF

TGFBETA SIGNAL CONVERTOR

T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA

Compositions Comprising Polypeptides having Xylanase Activity and Polypeptides having Arabinofuronosidase Activity

CELL SECRETED MINIBODIES AND USES THEREOF

Cells having solid tumor targeting backbone and use thereof

ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF

IMPROVED ANTIGEN BINDING RECEPTORS

HUMANIZED ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, VECTOR, CELL AND USE

CSPG4-TARGETING HUMANIZED CHIMERIC ANTIGEN RECEPTOR, IMMUNE EFFECTOR CELL EXPRESSING CHIMERIC ANTIGEN RECEPTOR, AND APPLICATIONS THEREOF

CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME

DOWNREGULATION OF MEMBRANE-BOUND PROTEINS BY RECEPTOR TAC TECHNOLOGY

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

CHIMERIC ANTIGEN RECEPTORS TARGETED TO PSCA

SARS-COV-2 THERAPIES

Chimeric ILT receptor compositions and methods

Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same

SYSTEMS FOR IN VIVO MONITORING OF IMMUNE CELLS IN PATIENTS UNDERGOING CELLULAR IMMUNOTHERAPY

CHIMERIC SWITCH RECEPTORS FOR THE CONVERSION OF IMMUNESUPPRESSIVE SIGNALS TO COSTIMULATORY SIGNALS

Chimeric Antigen Receptor

Methods and compositions for transducing lymphocytes and regulating the activity thereof

COMPOSITIONS AND METHODS FOR PRODUCING POLYPEPTIDES WITH A MODIFIED GLYCOSYLATION PATTERN IN PLANT CELLS

COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

CHIMERIC ANTIGEN RECEPTOR (CAR) WITH CD28 TRANSMEMBRANE DOMAIN

OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR

COMPOSITIONS AND USES OF CD45 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS

ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION

CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

UNIVERSAL DONOR CELLS

ANTIGEN BINDING RECEPTORS

ANTI-CD44 SINGLE-CHAIN ANTIBODY AND USE THEREOF IN PREPARING DRUG FOR TREATING TUMOR

METHODS AND COMPOSITIONS RELATING TO EX VIVO CULTURE AND MODULATION OF T CELLS

FUSION PROTEIN ENHANCING CELL THERAPY

PHARMACEUTICAL COMPOSITION COMPRISING CELL EXPRESSING CHIMERIC RECEPTOR

METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA

GLP-1/GLUCAGON DUAL AGONIST FUSION PROTEIN

CYTOKINE-BASED MULTI-EPITOPE PROTEIN FOR BINDING TO CCR7-POSITIVE CELLS

CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELLS RECOGNIZING CEA

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

CAL-T CONSTRUCTS AND USES THEREOF

SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE

ARTIFICIAL SYNAPSES

CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

GRP78 TARGETED ADOPTIVE CELL THERAPY

METHODS FOR CULTURING CELLS EXPRESSING ROR1-BINDING PROTEIN

ANTI-CD133 SINGLE-CHAIN ANTIBODY AND USE THEREOF IN PREPARATION OF DRUG FOR TREATING TUMOR

CHIMERIC ANTIGEN RECEPTOR-MODIFIED IMMUNE CELLS EXPRESSING A SECRETABLE BISPECIFIC TRAP PROTEIN AND USES THEREOF

ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

Enzymes for Sialylation of Glycans

BINDERS AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN

Engineered chimeric fusion protein compositions and methods of use thereof

CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS

COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING CELLS

MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY

CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED LYMPHOCYTE HAVING CYTOCIDAL EFFECT

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

PD-1 AND PD-L1 BINDING AGENTS

ANTI-TIM3 SINGLE-CHAIN ANTIBODY AND USE THEREOF IN PREPARING MEDICINE FOR TREATING TUMOR

UNIVERSAL CAR-NK CELL TARGETING VARIOUS EPITOPES OF HIV-1 GP160

Chimeric inhibitor molecules of complement activation

Promoter polynucleotide, signal polypeptide and use thereof

Reduced genome lacking toxin-antitoxin genes

CRISPR-Cas effector polypeptides and methods of use thereof

CHIMERIC ANTIGEN RECEPTOR CELLS TARGETING ROBO1, PREPARATION METHOD AND USE THEREOF

COMPOSITIONS AND METHODS TO TARGET ANTI-TNF-ALPHA ANTIBODY

Humanized anti-MUC1* antibodies

TECHNIQUE FOR PREPARING UNIVERSAL HUMANISED CAR19-DNT CELLS AND APPLICATION THEREFOR

Targeting anabolic drugs for accelerated fracture repair

MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME

CD20 BINDING MOLECULES AND USES THEREOF

Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof

Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer, infections and autoimmune disorders

METHOD FOR PREPARING RECOMBINANT HUMAN EXTRACELLULAR MATRIX STRUCTURAL PROTEIN

INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES

MODULATORS OF THE IMMUNE ESCAPE MECHANISM FOR UNIVERSAL CELL THERAPY

MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED NFKB SIGNALING

MHC MULTIMER EXPRESSION CONSTRUCTS AND USES THEREOF

TREATMENT OF CD30-POSITIVE CANCER

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF

MODIFIED BACTERIA AND USES THEREOF

D-domain containing polypeptides and uses thereof

CD22 BINDING MOLECULES AND USES THEREOF

BCMA chimeric antigen receptors and uses thereof

CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

Virulence Attenuated Bacteria Based Protein Delivery

Microvascular endothelial cell comprising a nucleic acid encoding an anti-TDP-43 fab

MODIFIED UROKINASE-TYPE PLASMINOGEN ACTIVATOR POLYPEPTIDES AND METHODS OF USE

ENGINEERED IMMUNE CELL EXPRESSING NK INHIBITORY MOLECULE AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR TARGETING CLDN18.2 AND USE THEREOF

TRANSGENIC PLANTS EXPRESSING A VARIABLE DOMAIN OF HEAVY-CHAIN ANTIBODY (VHH) THAT BINDS TO A SPHINGOLIPID OF A FUNGUS

USE OF THE CD2 SIGNALING DOMAIN IN SECOND-GENERATION CHIMERIC ANTIGEN RECEPTORS

CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND THEIR USE IN CAR-T CELLS

FULLY HUMANIZED BISPECIFIC CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD22 AND USE THEREOF

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

Combining iPSC derived effector cell types for immunotherapy use

Mesothelin-targetting antibodies, chimeric antigen receptors, and uses thereof

Anti-CD30 Antibodies and Methods for Treating CD30+ Cancer

SSTR-2 Binding Chimeric Antigen Receptors

HUMANIZED CD19 ANTIBODY AND USE THEREOF

INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES

VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS

Compositions and methods for TCR reprogramming using fusion proteins

TREM2 CHIMERIC RECEPTOR

HUMANIZED ACE2-FC FUSION PROTEIN FOR TREATMENT AND PREVENTION OF SARS-COV-2 INFECTION

NOVEL SIGNAL PEPTIDES GENERATED BY ATTENTION-BASED NEURAL NETWORKS

GENE THERAPY CONSTRUCTS AND METHODS OF USE

Dendritic cell tumor vaccine and uses thereof

ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE

Compositions for treating ectopic calcification disorders, and methods using same

Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor Microenvironment

Engineered T Cells

GENETICALLY MODIFIED NON-HUMAN ANIMAL EXPRESSING A B2M/FCRN FUSION PROTEIN

CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR HLA

Nucleic Acids, Vectors, Host Cells and Methods for Production of Fructosyltransferase from Aspergillus Japonicus

REGENERATIVE CAR-T CELLS

SYNTHETIC PROTEIN CIRCUITS DETECTING SIGNAL TRANSDUCER ACTIVITY

RSV F Protein Mutants

MODULAR POLYPEPTIDE LIBRARIES AND METHODS OF MAKING AND USING SAME

METHOD FOR OBTAINING CAR-NK CELLS

ANTI-CD171 CHIMERIC ANTIGEN RECEPTORS

IMMUNE CELLS OVEREXPRESSING CELL SIGNALING REGULATORY FACTOR INTRODUCED FROM OUTSIDE AND USE THEREOF

PROTEIN SECRETORY FACTOR WITH HIGH SECRETORY EFFICIENCY AND AN EXPRESSION VECTOR COMPRISING THE SAME

MARROW INFILTRATING LYMPHOCYTES (MILS) AS A SOURCE OF T-CELLS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) THEREAPY

MODIFIED NATURAL KILLER CELLS AND METHODS OF USING THE SAME

BISPECIFIC BINDING CONSTRUCTS

Dual EGFR-MUC1 Chimeric Antigen Receptor T Cells

ANTIBODIES SPECIFIC TO ABCB5 AND USES THEREOF

FUSION PROTEIN FOR REVERSING TUMOR MICROENVIRONMENT AND USE THEREOF

METHODS AND COMPOSITIONS RELATING TO CHIMERIC ANTIGEN RECEPTORS

FUSION POLYPEPTIDES FOR TARGET PEPTIDE PRODUCTION

UNIVERSAL DONOR CELLS

UNIVERSAL DONOR CELLS

METHODS FOR MAKING T CELL COMPOSITIONS

METHODS AND COMPOSITIONS FOR SYNTHESIZING IMPROVED SILK FIBERS

CD19 BINDING MOLECULES AND USES THEREOF

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

ANTI-ROR-2 ANTIBODIES AND METHODS OF USE

CLAUDIN18.2 BINDING MOIETIES AND USES THEREOF

Peptide-HLA complexes and methods of producing same

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY

INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE

ACE2 MUTEINS AND METHODS OF USING THE SAME

MULTIMERS, TETRAMERS & OCTAMERS